NAC OCD trial

Recruitment has now closed

(...which means results are on their way!

ETA 2021)


Obsessive Compulsive Disorder (OCD) is a mental health condition which affects more than 500,000 Australians. The symptoms of OCD can vary greatly between individuals. Without adequate treatment, OCD can cause significant distress and impairment. 


N-acetylcysteine, or NAC for short, is an amino acid supplement which has been used in medicine for decades. We are researching its effects for improving OCD symptoms in a government funded, randomised, double blind, placebo controlled study

  • Adults between 18-75 years of age

  • Diagnosed with OCD

  • Currently receiving treatment for OCD, but still experience symptoms

  • Able to attend an appointment once/month, over a 6-month period



**Please note, as of May, 2020 recruitment for this trial has closed. The researchers will begin data analysis shortly and hope to be able to share results in 2021**

Enter your contact details below and one of our staff members will be in touch to discuss the trial with you. However, please note, recruitment for this trial has now closed. 

By providing your contact details, you consent to the storage of this information on our secure research database. This information will be destroyed at the completion of the trial. 

© 2023 by Make A Change.
Proudly created with

TMCREC project #279; UQ MREC project #2016001720; WSU HREC project #H12181